{"id":2882,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2023-02-10","marketCap":585.7479248046875,"name":"Mineralys Therapeutics Inc","phone":"18883786240","outstanding":41.11000061035156,"symbol":"MLYS","website":"https://mineralystx.com/","industry":"Biotechnology"},"price":14.15625,"year":2024,"month":2,"day":14,"weekday":"Wednesday","title":"Historical Performance of Mineralys Therapeutics Inc Stock Compared to Industry Benchmarks","date":"2024-02-14","url":"/posts/2024/02/14/MLYS","content":[{"section":"Introduction","text":"Mineralys Therapeutics Inc is a pharmaceutical company operating in the biotechnology sector. To analyze the historical performance of Mineralys Therapeutics Inc stock, we will compare its stock performance to relevant industry benchmarks."},{"section":"Methodology","text":"To assess the performance, we will use a selected industry benchmark index as a reference. This benchmark could be a popular stock market index that represents the overall performance of the biotechnology sector or a custom index specifically tailored for comparison purposes."},{"section":"Time Period","text":"The analysis will cover a specific time period, typically spanning several years, to capture meaningful trends and fluctuations in stock prices. The timeframe chosen should be consistent across all data points for accurate comparisons."},{"section":"Data Collection","text":"The stock prices of Mineralys Therapeutics Inc will be collected for the selected time period, along with the corresponding benchmark index prices. Historical stock prices can be obtained from financial databases or online stock market platforms."},{"section":"Calculating Returns","text":"To compare the performance, we will calculate the returns of Mineralys Therapeutics Inc stock and the benchmark index. Returns will be calculated as a percentage change in stock prices over the chosen time period."},{"section":"Comparison and Analysis","text":"By comparing the returns of Mineralys Therapeutics Inc stock to the benchmark index returns, we can objectively evaluate the stock's performance. Positive returns higher than the benchmark indicate outperformance, while negative returns lower than the benchmark suggest underperformance."},{"section":"Context","text":"It is important to consider external factors that may have influenced the stock's performance during the analyzed period. These factors can include market conditions, industry trends, company announcements, regulatory changes, or economic indicators."},{"section":"Conclusion","text":"Based on the comparison and analysis, a conclusion can be drawn regarding the historical performance of Mineralys Therapeutics Inc stock relative to the industry benchmarks. Additional insights can be provided based on the observed trends and factors impacting the stock's performance."}],"tags":["CrossOver21","Long","Biotechnology"],"news":[{"category":"company","date":1707471191,"headline":"Mineralys: 2nd Half 2024 Hypertension Data Readout","id":125703320,"image":"https://media.gettyimages.com/id/1984444724/photo/rapid-test-kit-for-rocky-mountain-spotted-fever-antibodies-igg-and-igm-test.jpg?b=1\u0026s=170667a\u0026w=0\u0026k=20\u0026c=_-fT3bkrBpUGDtkD343Hygr86MSAz7tZsPQ5mydsR20=","symbol":"MLYS","publisher":"SeekingAlpha","summary":"Mineralys has 2 ongoing studies evaluating use of lorundrostat for the treatment of patients with uncontrolled or resistant hypertension. Click here to read more about them.","url":"https://seekingalpha.com/article/4669031-mineralys-2nd-half-2024-hypertension-data-readout"},{"category":"company","date":1707451320,"headline":"Mineralys Therapeutics Equity Sales: Investor Impact Report","id":125724132,"image":"","symbol":"MLYS","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3341530692"},{"category":"company","date":1707451320,"headline":"Mineralys Therapeutics Announces Strategic Purchase Agreement","id":125724131,"image":"","symbol":"MLYS","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3341530690"},{"category":"company","date":1707451260,"headline":"Mineralys Therapeutics Secures $120M in Private Placement","id":125724134,"image":"","symbol":"MLYS","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3341529969"},{"category":"company","date":1707441840,"headline":"Commit To Purchase Mineralys Therapeutics At $12.50, Earn 45.9% Annualized Using Options","id":125724136,"image":"","symbol":"MLYS","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3342229461"},{"category":"company","date":1707397200,"headline":"Mineralys Therapeutics Announces $120 Million Private Placement Financing","id":125646370,"image":"https://media.zenfs.com/en/globenewswire.com/90226c9fda7ac1f347f758bb5fb98743","symbol":"MLYS","publisher":"Yahoo","summary":"RADNOR, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (“CKD”) and other diseases driven by abnormally elevated aldosterone, today announced that it has entered into a securities purchase agreement with institutional accredited investors to sell securities in a private placement financing (the “PIPE”) for gross proceeds of approximately $1","url":"https://finance.yahoo.com/news/mineralys-therapeutics-announces-120-million-130000367.html"},{"category":"company","date":1707394140,"headline":"Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session","id":125659929,"image":"","symbol":"MLYS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3340007182"},{"category":"company","date":1707384300,"headline":"Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday","id":125659084,"image":"","symbol":"MLYS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3339732725"},{"category":"company","date":1707383040,"headline":"Mineralys Rallies After PIPE Offering Prices Above Wednesday Close","id":125717992,"image":"https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png","symbol":"MLYS","publisher":"MarketWatch","summary":"By Rob Curran Shares of Mineralys Therapeutics rose sharply after the biotech concern priced a follow-on sale of stock above its Wednesday closing price. Its...","url":"https://www.marketwatch.com/story/mineralys-rallies-after-pipe-offering-prices-above-wednesday-close-40cbb60e"},{"category":"company","date":1707382200,"headline":"Mineralys Therapeutics stock jumps on $120M private placement financing","id":125724143,"image":"","symbol":"MLYS","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3339676380"},{"category":"company","date":1707376440,"headline":"Mineralys Therapeutics to sell 8.9M shares at $13.50 in private placement","id":125724145,"image":"","symbol":"MLYS","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3339535230"},{"category":"company","date":1707376140,"headline":"12 Health Care Stocks Moving In Thursday's Pre-Market Session","id":125655147,"image":"","symbol":"MLYS","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3339529572"},{"category":"company","date":1706839380,"headline":"Catalyst watch: Alibaba earnings, World Defense Show, Fed speakers unleashed and Super Bowl buzz","id":125486661,"image":"","symbol":"MLYS","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3330555222"}]}